Literature DB >> 11341103

Assessing depression in systemic lupus erythematosus: determining reliable change.

G L Iverson1, D C Sawyer, L M McCracken, E Kozora.   

Abstract

Systemic lupus erythematosus (SLE) can follow an unpredictable course. Clinicians and researchers use various self-report inventories to track aspects of the patient's functioning during the course of the illness (e.g. health status, pain, fatigue, quality of life and psychological status). These self-report inventories are used to measure improvement or deterioration as a function of the natural history of the disease process, or as a function of response to treatment. Proper interpretation of scores derived from these inventories requires an understanding of their psychometric properties, in particular, their reliability. It is important to calculate reliable change difference scores for tests commonly used in rheumatology so clinicians can determine if a change score is a reliable indicator of improvement or deterioration in individual patients (i.e. the change score is not likely to be due to measurement error). The purpose of this article is to illustrate the use of the reliable change difference scores when assessing depression in patients with SLE using the Beck Depression Inventory (BDI).

Entities:  

Mesh:

Year:  2001        PMID: 11341103     DOI: 10.1191/096120301680416959

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

1.  Comparing post-concussive neurocognitive test data to normative data presents risks for under-classifying "above average" athletes.

Authors:  Philip Schatz; Stacey Robertshaw
Journal:  Arch Clin Neuropsychol       Date:  2014-09-01       Impact factor: 2.813

Review 2.  Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus.

Authors:  Eduardo de Almeida Macêdo; Simone Appenzeller; Lilian Tereza Lavras Costallat
Journal:  Rheumatol Int       Date:  2017-09-22       Impact factor: 2.631

Review 3.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

4.  Utility of 1 Measurement Versus Multiple Measurements of Near Point of Convergence After Concussion.

Authors:  Nathan Ernst; Philip Schatz; Alicia M Trbovich; Kouros Emami; Shawn R Eagle; Anne Mucha; Michael W Collins; Anthony P Kontos
Journal:  J Athl Train       Date:  2020-08-01       Impact factor: 2.860

5.  Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus.

Authors:  Erinn S Kellner; Pui Y Lee; Yi Li; Juliana Switanek; Haoyang Zhuang; Mark S Segal; Eric S Sobel; Minoru Satoh; Westley H Reeves
Journal:  J Neuroimmunol       Date:  2010-04-22       Impact factor: 3.478

6.  An Intervention to Reduce Psychosocial and Biological Indicators of Stress in African American Lupus Patients: The Balancing Lupus Experiences with Stress Strategies Study.

Authors:  Edith M Williams; Megan Penfield; Diane Kamen; James C Oates
Journal:  Open J Prev Med       Date:  2014-01

Review 7.  Neurological Disease in Lupus: Toward a Personalized Medicine Approach.

Authors:  Sarah McGlasson; Stewart Wiseman; Joanna Wardlaw; Neeraj Dhaun; David P J Hunt
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.